Showing 1 to 10 of 14 Clinical Trials
CLINICAL TRIAL
    Trial No
    ClinicalTrials.gov ID
Principal Investigator
Coordinator
Phase I Open-label, Multi-center Study to Evaluate the Safety, Tolerability, Dosimetry, and Preliminary Activity of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
    CFXX489A12101
    NCT06562192
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL  
Breast
Colon and Rectum
Non Small Cells - Lung
Pancreas
Dr. Nicolas Plouznikoff

Adeline Hamon
  514-890-8000 poste 30737
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
    MK-9999-02A
    NCT06428409
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL  
Colon and Rectum
Hepatic Ducts
Pancreas
Dr. Francine Aubin

Adeline Hamon
  514-890-8000 poste 30737
A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers
    MK-5909-005 (REJOICE-GI01)
    NCT06864169
     Recruiting
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL  
Colon and Rectum
Hepatic Ducts
Oesophagus
Pancreas
Stomach
Dr. Francine Aubin

Adeline Hamon
  514-890-8000 poste 30737
A Phase 1/2 Study to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers
    MK-9999-02A
    NCT06428409
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN  

Colon and Rectum
Hepatic Ducts
Pancreas
Dr. Victoria Mandilaras

Rodrigo Skowronski
  514-934-1934 poste 36275
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS  

Pancreas Dr. Nicolas Marcoux

Mélanie Croussette
  418-525-4444 poste 22637
Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX: a Prospective, Pilot Study
    PDAC-LIV
    NCT06349278
     Recruiting
CHU DE QUEBEC – UNIVERSITE LAVAL
HOPITAL DE L'ENFANT-JESUS  

Pancreas Dr. Alexandre Brind’Amour

Maryse Gingras
  418-525-4444 poste 15781
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
    AT-PANC-101
    NCT04002479
     Recruiting
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS  

Pancreas Dr. Corey Miller

Pricille Cleveaux
  514-340-8222 poste 24480
Quebec Pancreas Cancer Study
    QPCS
    NCT04104230
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN  

Pancreas Dr. George Zogopoulos

Adeline Cuggia
  514-934-1934 poste 76333
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CIUSSS DE L'ESTRIE – CENTRE HOSP. UNIV. DE SHERBROOKE
HOPITAL FLEURIMONT  

Pancreas Dr. Frédéric Lemay

Michelle Roy
  819-346-1110 poste 12848
A Phase III Trial of Perioperative Versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
    PAC.3 (A021806)
    NCT04340141
     Recruiting
CENTRE UNIVERSITAIRE DE SANTE MCGILL
SITE GLEN  

Pancreas Dr. George Zogopoulos

Jacqueline Lewis
  514-934-1934 poste 34909